✦ LIBER ✦

Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate

✍ Scribed by Mack Roach III; Vivian Weinberg; Patrick W. McLaughlin; Gary Grossfeld; Howard M. Sandler

Book ID: 117264981
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 265 KB
Volume: 61
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(02)02425-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

External beam radiotherapy for carcinoma

External beam radiotherapy for carcinoma of the prostate

✍ Robert H. Sagerman; H. C. Chun; Gerald A. King; Chung T. Chung; Pankaj S. Dalal 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 686 KB

and 1981. The results for the 239 patients treated with radical intent are reported here. All patients received 60 to 70 Gy to the prostate with megavoltage beam irradiation; 142 with a small field (10 X 10 cm) 360" rotational technique for Stage A, B, or C disease and 69 with a four-field pelvic br

The importance of an exponential prostat

The importance of an exponential prostate-specific antigen decline after external beam radiotherapy for intermediate risk prostate cancer

✍ Guila Delouya; Gabriel Kaufman; Marie-Pierre Sylvestre; Thu-Van Nguyen; Jean-Pau 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 215 KB

Evaluation of radiation effect, tumor di

Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma

✍ Juanita M. Crook; Yasir A. Bahadur; Susan J. Robertson; Gad A. Perry; Bernd A. E 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

tients with residual tumor in 1 or more biopsies at 10 -78 months of follow-up Regional Cancer Centre, Ottawa, Ontario, Canwere selected for review. All patients had undergone biopsy on more than one ada. occasion. The 198 biopsies were stained for PSA, high molecular weight keratin,

Radiotherapy for localized prostate carc

Radiotherapy for localized prostate carcinoma : The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

✍ Juanita M. Crook; Yasir A. Bahadur; R. Gregory Bociek; Gad A. Perry; Susan J. Ro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Background: The objective of this study was to correlate the failure pattern of localized prostate carcinoma after radiotherapy (rt) with pretreatment (pretx) psa and post-rt nadir psa, using systematic biopsies and serum psa in the assessment of outcome. ## Methods: From january 1990 to febru

Prostate-Specific Antigen Kinetics After

Prostate-Specific Antigen Kinetics After Brachytherapy or External Beam Radiotherapy and Neoadjuvant Hormonal Therapy

✍ Michael Pinkawa; Karin Fischedick; Marc D. Piroth; Bernd Gagel; Holger Borchers; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Recurrence-free survival rates after ext

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate-specific antigen era : What should we expect?

✍ Deepak Khuntia; Chandana A. Reddy; Arul Mahadevan; Eric A. Klein; Patrick A. Kup 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

## Abstract ## BACKGROUND The objective of the current study was to report biochemical recurrence–free survival (bRFS) rates among men with T1–T3 prostate carcinoma who were treated with external‐beam radiotherapy (RT) at the Cleveland Clinic Foundation (Cleveland, OH). ## METHODS In total, 1352